The removal order stemmed from a lese majeste case filed against Thanatorn over the statement by the Digital Economy and Society (DES) Ministry on January 20.
The statement questions the role of the royally-owned Siam Bioscience pharmaceutical company in Thailand’s Covid-19 vaccination plans. Thanathorn claimed Siam Bioscience has been unfairly handed the contract to manufacture the AstraZeneca vaccine.
On Monday, the court said Thanathorn's statement did not affect the Kingdom's security since its aim was merely to criticise the government over its Covid-19 vaccination plans.
Published : February 08, 2021
By : The Nation